文献速递中药与中成药合理使用中医内科

UPLC-MS/MS法测定连丹消炎方四种活性成分在溃疡性结肠炎大鼠与对照大鼠的药代动力学

Pharmacokinetic Study of Four Major Bioactive Components of Liandan Xiaoyan Formula in Ulcerative Colitis and Control Rats Using UPLC-MS/MS.
PubMed 文献 · Front Pharmacol · 2022-07-04

本研究建立UPLC-MS/MS法同时测定连丹消炎方中穿心莲内酯、脱水穿心莲内酯、1-甲氧基羰基-β-咔啉和4-甲氧基-5-羟基-斑鸠菊内酯在大鼠血清中的浓度。方法学验证良好,并用于比较DSS诱导的溃疡性结肠炎大鼠与对照大鼠口服连丹消炎方后的药代动力学特征,发现四种成分在两组均快速吸收,但UC组暴露水平更高。

要点

  • 建立的UPLC-MS/MS法可同时测定连丹消炎方四种主要活性成分。
  • 溃疡性结肠炎大鼠口服连丹消炎方后四种成分暴露水平高于对照大鼠。
  • 该药代动力学数据为连丹消炎方的临床应用提供了科学依据。

核心结论

  • 连丹消炎方四种主要活性成分在溃疡性结肠炎和对照大鼠口服后均快速吸收,且溃疡性结肠炎组暴露水平更高。

研究设计与样本

  • 采用UPLC-MS/MS法测定大鼠血清中四种成分,并比较DSS诱导的溃疡性结肠炎大鼠与对照大鼠口服连丹消炎方后的药代动力学。

主要发现

  • 方法线性良好(R² ≥ 0.9970),日内和日间准确度在±11.58%以内,日内和日间精密度小于13.79%。
  • 四种主要活性成分在两组大鼠口服后均快速吸收,溃疡性结肠炎组暴露水平更高。

关键数值与推荐

  • 线性回归系数R² ≥ 0.9970;日内和日间准确度在±11.58%以内;日内和日间精密度小于13.79%。

临床怎么用

  • 该药代动力学特征可为连丹消炎方在溃疡性结肠炎临床应用中提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liandan Xiaoyan Formula (LXF), a classic Traditional Chinese medicine (TCM) formula, is composed of two Chinese herbal medicines for treating bowel disease under the TCM theory. This study aimed to develop a rapid, stable, sensitive, and reliable method based on ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) to simultaneously determine four major bioactive components of LXF (andrographolide, dehydroandrographolide, 1-methoxicabony-β-carboline, 4-methoxy-5-hydroxy-canthin-6-one) in rat serum and evaluate the pharmacokinetic characteristics of LXF in ulcerative colitis (UC) and control rats. After pretreating by protein precipitation with methanol, separation was performed on a UPLC C18 column using gradient elution with a mobile phase consisting of acetonitrile and 0.1% formic acid at a flowing rate of 0.4 ml/min. Detection was performed on Triple-TOF™ 5600 mass spectrometry set at the positive ionization and multiple reaction monitoring (MRM) mode. The validated method showed good linearity (R 2 ≥ 0.9970), the intra- and inter-day accuracy were within ±11.58%, whereas the intra- and inter-day precision were less than 13.79%. This method was validated and applied to compare the pharmacokinetic profiles of the analytes in serum of UC induced by dextran sulphate sodium (DSS) and control rats after oral administration of LXF. The results showed that four major bioactive components of LXF were quickly absorbed after oral administration in both groups, with higher exposure levels in the UC group. This relationship between the active ingredients' pharmacokinetic properties provided essential scientific information for applying LXF in clinical.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang K, Lu Z, Wang Q, et al. Pharmacokinetic Study of Four Major Bioactive Components of Liandan Xiaoyan Formula in Ulcerative Colitis and Control Rats Using UPLC-MS/MS. Front Pharmacol. 2022. PMID: 35860031. doi:10.3389/fphar.2022.936846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。